TCR Biotherapeutics Relocates to UWM Innovation Campus
TCR Biotherapeutics has established its research laboratory and offices to the University of Wisconsin-Milwaukee’s Innovation Campus. The 25,000 sq. ft state-of-the-art facility will help the company advance its research in T cell-based therapeutics for autoimmune disease and increase collaboration with other academic and biotech companies in the region. Opened in 2014, the UWM Accelerator Building in home to researchers from UWM, the Medical College of Wisconsin, Concordia University Wisconsin, and other academic institutions. The new location significantly expands the technical resources available to TCR Biotherapeutics and adds specialized infrastructure to support preclinical drug development. We invite you to follow us on social media (click icons below) to learn more about TCR Biotherapeutics. If you have any questions, please visit our contact us page.
Comments are closed